GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Other Long-Term Liabilities

MYNZ (Mainz Biomed NV) Other Long-Term Liabilities : $0.55 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Other Long-Term Liabilities?

Mainz Biomed NV's other long-term liabilities for the quarter that ended in Jun. 2024 was $0.55 Mil.

Mainz Biomed NV's quarterly other long-term liabilities declined from Sep. 2023 ($0.80 Mil) to Dec. 2023 ($0.73 Mil) and declined from Dec. 2023 ($0.73 Mil) to Jun. 2024 ($0.55 Mil).

Mainz Biomed NV's annual other long-term liabilities declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil) but then increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($0.73 Mil).


Mainz Biomed NV Other Long-Term Liabilities Historical Data

The historical data trend for Mainz Biomed NV's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Other Long-Term Liabilities Chart

Mainz Biomed NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
- - - - -

Mainz Biomed NV Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mainz Biomed NV Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Mainz Biomed NV Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Mainz Biomed NV Business Description

Traded in Other Exchanges
Address
Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.